Stock listing
VIR Stock Price, News, Filings & Events — Vir Biotechnology, Inc.
Selected listing: VIR · BX · CHF · CH
This page tracks Vir Biotechnology, Inc.'s VIR:BX listing on BX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VIR:BX. VIR:BX is the stock-level entry point for investors researching Vir Biotechnology, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Vir Biotechnology, Inc. is a public company traded under the ticker VIR in the American market. The company has a market capitalization of approximately $1.47 billion. Vir focuses on developing innovative therapies for infectious diseases and has a commitment to advancing its scientific research and product pipeline.
- Ticker
- VIR:BX
- Asset type
- Stock
- Market cap
- $1.80B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BX
- Currency
- CHF
Vir Biotechnology, Inc. VIR:BX stock context
This page tracks Vir Biotechnology, Inc.'s VIR:BX listing on BX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VIR:BX. VIR:BX is the stock-level entry point for investors researching Vir Biotechnology, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Vir Biotechnology, Inc. is a public company traded under the ticker VIR in the American market. The company has a market capitalization of approximately $1.47 billion. Vir focuses on developing innovative therapies for infectious diseases and has a commitment to advancing its scientific research and product pipeline.
Latest news from Vir Biotechnology, Inc.
Vir Biotechnology to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
August 31, 2026
Vireo Growth Receives Regulatory Approval and Completes Acquisition of PharmaCann Colorado Retail Assets
August 7, 2026
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2026 Financial Results
August 5, 2026
Vir Biotechnology Announces Chief Financial Officer Transition
July 24, 2026
Vir Biotechnology to Host Conference Call for Second Quarter 2026 Financial Results
July 22, 2026
Vir Biotechnology, Inc. earnings calls
Vir Biotechnology, Inc. (VIR) Q2 2026 Earnings Call
August 5, 2026 · Replay with transcript and chapters
Vir Biotechnology, Inc. (VIR) Q1 2026 Earnings Call
May 6, 2026 · Replay with transcript and chapters
Vir Biotechnology, Inc. (VIR) Q4 2025 Earnings Call
February 23, 2026 · Replay with transcript and chapters
Vir Biotechnology, Inc. (VIR) Q3 2025 Earnings Call
November 5, 2025 · Replay with transcript and chapters
Vir Biotechnology, Inc. (VIR) Q2 2025 Earnings Call
August 6, 2025 · Replay with transcript and chapters
Vir Biotechnology, Inc. (VIR) Q1 2025 Earnings Call
May 7, 2025 · Replay with transcript and chapters
Research Vir Biotechnology, Inc.
Vir Biotechnology, Inc. investor report
Review AI stock analysis and investor report context for VIR:BX.
Vir Biotechnology, Inc. company profile
View the public company page for Vir Biotechnology, Inc. on 6ix.
Vir Biotechnology, Inc. news
Read company news and market updates connected to Vir Biotechnology, Inc..
Vir Biotechnology, Inc. investor events
Find investor webinars, events, and replay context for Vir Biotechnology, Inc..
Alternate listings
VIR:NASDAQ
US · USD
Alternate listing for Vir Biotechnology, Inc.; the primary context on this page is VIR:BX.
VIR:BMV
MX · MXN
Alternate listing for Vir Biotechnology, Inc.; the primary context on this page is VIR:BX.
VIR:BIVA
MX · MXN
Alternate listing for Vir Biotechnology, Inc.; the primary context on this page is VIR:BX.
VIR:BOATS
US · USD
Alternate listing for Vir Biotechnology, Inc.; the primary context on this page is VIR:BX.